Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.08% Nasdaq Down0.11%

Biogen Idec Inc. (BIIB)

-NasdaqGS

232.62 May 23, 4:00PM EDT

Add to Portfolio
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.1
Mean Recommendation (last week):2.1
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)Compare to Industry

Price Target Summary
Mean Target:221.41
Median Target:227.00
High Target:270.00
Low Target:158.51
No. of Brokers:23

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Dec 17, 2012Canaccord GenuityInitiated Hold
Oct 4, 2012OppenheimerDowngradeOutperformPerform
Sep 9, 2012UBSDowngradeBuyNeutral
Dec 8, 2011Barclays CapitalInitiated Overweight
Sep 8, 2011UBSUpgradeNeutralBuy
Aug 17, 2011OppenheimerUpgradePerformOutperform
Jun 20, 2011Deutsche BankUpgradeHoldBuy
Apr 14, 2011MP AdvisorsUpgradeMarket PerformOutperform
Feb 23, 2011RBC Capital MktsUpgradeSector PerformOutperform
Nov 15, 2010UBSInitiated Neutral

More Upgrades & Downgrades for BIIB

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0000
Buy0000
Hold0000
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.